These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1533 related articles for article (PubMed ID: 30894700)

  • 1. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification in diabetic kidney disease.
    Liu Z; Liu J; Wang W; An X; Luo L; Yu D; Sun W
    Front Endocrinol (Lausanne); 2023; 14():1133970. PubMed ID: 37455912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: the role of epigenetics in the metabolic memory of diabetic complications.
    Chen Z; Malek V; Natarajan R
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F327-F339. PubMed ID: 38961840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in epigenetics of acute and chronic kidney diseases.
    Reddy MA; Natarajan R
    Kidney Int; 2015 Aug; 88(2):250-61. PubMed ID: 25993323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).
    Qu P; Li L; Jin Q; Liu D; Qiao Y; Zhang Y; Sun Q; Ran S; Li Z; Liu T; Peng L
    Int J Mol Med; 2024 Nov; 54(5):. PubMed ID: 39301658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
    Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
    J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.
    Xu L; Natarajan R; Chen Z
    Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic kidney diseases revisited: A new perspective for a new era.
    Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
    Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNA methylation in diabetic kidney disease: A new perspective.
    Akhouri V; Majumder S; Gaikwad AB
    Life Sci; 2023 Dec; 335():122256. PubMed ID: 37949210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.
    Hirakawa Y; Tanaka T; Nangaku M
    J Diabetes Investig; 2017 May; 8(3):261-271. PubMed ID: 28097824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study.
    Smyth LJ; Kilner J; Nair V; Liu H; Brennan E; Kerr K; Sandholm N; Cole J; Dahlström E; Syreeni A; Salem RM; Nelson RG; Looker HC; Wooster C; Anderson K; McKay GJ; Kee F; Young I; Andrews D; Forsblom C; Hirschhorn JN; Godson C; Groop PH; Maxwell AP; Susztak K; Kretzler M; Florez JC; McKnight AJ
    Clin Epigenetics; 2021 May; 13(1):99. PubMed ID: 33933144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Kourtidou C; Tziomalos K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis.
    Kuo FC; Chao CT; Lin SH
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs-towards precision medicine in diabetic kidney disease?
    Panchapakesan U; Pollock C
    Clin Sci (Lond); 2016 Sep; 130(18):1599-602. PubMed ID: 27503944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
    Tonna S; El-Osta A; Cooper ME; Tikellis C
    Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Lu HC; Dai WN; He LY
    Diabetes Metab Syndr Obes; 2021; 14():329-344. PubMed ID: 33519221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease.
    Sheng X; Qiu C; Liu H; Gluck C; Hsu JY; He J; Hsu CY; Sha D; Weir MR; Isakova T; Raj D; Rincon-Choles H; Feldman HI; Townsend R; Li H; Susztak K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29013-29024. PubMed ID: 33144501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.